Skip to main content
Keith Ligon, MD, Pathology, Boston, MA

KeithLLigonMDPhD

Pathology • Boston, MA

Molecular Genetics, Neuropathology, Anatomic Pathology, Pediatric Pathology

Chief of Neuropathology MGB-BWH-DFCI, Associate Professor of Pathology, Harvard Medical School/Brigham and Women's Hospital/Dana-Farber Cancer Institute/Boston Children's Hospital

Join to view full profile

Dr. Ligon is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Ligon's full profile

Already have an account?

  • Office

    75 Francis Street
    Boston, MA 02115
    Phone+1 617-732-5500

Summary

  • Dr. Keith Ligon is Pathologist and Chief of Neuropathology at the MGB-Brigham and Women's Hospital and Dana-Farber Cancer Institute in Boston, MA. He is affiliated with multiple hospitals in the area, including Mass General Brigham's Brigham and Women's Hospital, Dana-Farber Cancer Institute, and Boston Children's Hospital. He received his medical degree from MD Anderson Cancer Center and McGovern Medical School at UTHealth and has been in practice 20 years. He specializes in neuropathology, anatomic pathology, pediatric pathology, and molecular diagnostics. He is experienced in oncologic pathology. He has more than 200 publications and over 500 citings.

Education & Training

  • Brigham and Women's Hospital
    Brigham and Women's HospitalResidency, Pathology-Anatomic and Clinical, 1997 - 2001
  • McGovern Medical School at UTHealth
    McGovern Medical School at UTHealthClass of 1997
  • Brigham and Women's Hospital
    Brigham and Women's HospitalFellowship, Neuropathology

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2001 - 2025
  • American Board of Pathology Anatomic Pathology
  • American Board of Pathology Neuropathology

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Immunophenotyping of Pediatric Brain Tumors: Correlating Immune Infiltrate with Histology, Mutational Load, and Survival and Assessing Clonal T Cell Response  
    Isaac H Solomon, Mark W Kieran, Gabriel K Griffin, Pratiti Bandopadhayay, Jerome Ritz, Ashley S Plant, Keith L Ligon, Glenn Dranoff, Journal of Neuro-Oncology

Press Mentions

  • Weighing Cancer Cells Helps Predict Treatment Outcomes
    Weighing Cancer Cells Helps Predict Treatment OutcomesOctober 14th, 2021
  • Cancer Drug Response and Outcome Predicted from Cell Mass Changes
    Cancer Drug Response and Outcome Predicted from Cell Mass ChangesOctober 7th, 2021
  • New Study Finds Link Between Patient Survival and Changes in Tumor Cell Mass in Brain Cancer
    New Study Finds Link Between Patient Survival and Changes in Tumor Cell Mass in Brain CancerOctober 6th, 2021
  • Join now to see all

Grant Support

  • Shared Resources CoreNational Cancer Institute2011–2012
  • OLIG Function In CNS Development And TumorigenesisNational Institute Of Neurological Disorders And Stroke2006–2008
  • OLIG Function In CNS Development And TumorigenesisNational Institute Of Neurological Disorders And Stroke2004–2005

Dr. Keith Ligon, Dr. Keith Ligon, MD, Dr. K Ligon, Dr. Keith L Ligon